Harrisvaccines focuses on improving animal health and enhancing productivity in the swine, cattle and farmed shrimp industries. Using state-of-the-art advanced molecular science, Harrisvaccines employs two unique RNA platforms to develop products for animal diseases. Our proprietary Alphavirus RNA Particle technology allows Harrisvaccines to develop RNA-based products which enable differentiation of infected from vaccinated animals (DIVA), an important tool in the control and eradication of animal diseases.